Abstract:Antibody discovery technologies, essential for research and therapeutic applications, have evolved significantly since the development of hybridoma technology. Various in vitro (display) and in vivo (animal immunization and B cell-sequencing) workflows have led to the discovery of antibodies against diverse antigens. Despite this success, standard display and B-cell sequencing-based technologies are limited to targets that can be produced in a soluble form. This limitation inhibits the screening of function-inducing antibodies, which require the target to be expressed in cells to monitor function or signaling, and antibodies targeting proteins that maintain their physiological structure only when expressed on cell membranes, such as G-protein coupled receptors (GPCRs). A high-throughput two-cell screening workflow, which localizes an antibody-secreting cell (ASC) and a cell expressing the target protein in a microenvironment, can overcome these challenges. To make function-first plasma cell-based antibody discovery accessible and scalable, we developed hydrogel Nanovials that can capture single plasma cells, target-expressing cells, and plasma cell secretions (antibodies). The detection and isolation of Nanovials harboring the antigen-specific plasma cells are then carried out using a flow cytometry cell sorter - an instrument that is available in most academic centers and biopharmaceutical companies. The antibody discovery workflow employing Nanovials was first validated in the context of two different cell membrane-associated antigens produced in recombinant form. We analyzed over 40,000 plasma cells over two campaigns and were able to identify a diversity of binders that i) exhibited high affinity (picomolar) binding, ii) targeted multiple non-overlapping epitopes and iii) demonstrated high developability scores. A campaign using the two-cell assay targeting the immune checkpoint membrane protein PD-1 yielded cell binders with similar EC50s to clinically used Pembrolizumab and Nivolumab. The highest selectivity for binders was observed for sorted events corresponding with the highest signal bound to target cells on Nanovials. Overall, Nanovials can provide a strong foundation for function-first antibody discovery, yielding direct cell binding information and quantitative data on prioritization of hits with flexibility for additional functional readouts in the future.

Protocol for isolating antigen-specific monoclonal antibodies from immunized mice utilizing the Beacon platform

Isolation of human monoclonal antibodies from peripheral blood B cells

Assuring Clonality on the Beacon Digital Cell Line Development Platform

High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics

A nanowell platform to identify, sort and expand high antibody-producing cells

Rapid Specificity Determination and FACS Selection of Plasma Cells for Single Cell Antibody Cloning

Flotation-Based T Cell Isolation, Activation, and Expansion from Human Peripheral Blood Mononuclear Cell Samples Using Microbubbles

P28-S Digging Deeper and Faster into Proteome by IgY-Immunoaffinity Fractionation

FB5P-seq-mAbs: monoclonal antibody production from FB5P-seq libraries for integrative single-cell analysis of B cells

Generation and Screening of Antigen-Specific Nanobodies from Mammalian Cells Expressing the BCR Repertoire Library Using Droplet-Based Microfluidics

A Microfluidic Chip For Screening And Sequencing Of Monoclonal Antibody At A Single-Cell Level

Combined approach of selective and accelerated cloning for microfluidic chip‐based system increases clone specific productivity

Antigen-Specific Single B Cell Sorting and Monoclonal Antibody Cloning in Guinea Pigs

A SMART method for efficiently isolating monoclonal antibodies from individual rhesus macaque memory B cells

Abstract 2382: KY-CLC-mouse: a common light chain bispecific antibody discovery platform

A protocol for high-throughput screening for immunomodulatory compounds using human primary cells

A SMART method for isolating monoclonal antibodies from individual rhesus macaque memory B cells

Developing a workflow for the isolation of hybridoma cells producing fully human antigen-specific antibodies using a surface IgG detection method

A Bench-Top Approach for Isolation of Single Antibody Producing Chinese Hamster Ovary (CHO) Cells Using a Microwell-Based Microfluidic Device

Function-first discovery of high affinity monoclonal antibodies using Nanovial-based plasma B cell screening